Cardiometabolic disease moves through stages — overweight, obesity, pre-diabetes, type 2 diabetes, cardiovascular disease. Most plans only feel the cost at Stage 4 or 5, when claims are largest and the damage is hardest to undo.
Onsera works upstream. One continuous program — predictive risk modeling, integrated clinical care, behavior change, and disciplined medication management — that catches participants earlier in the progression, and keeps them there.
Onsera is a cardiometabolic care platform designed to predict, manage, and reduce population health risk—while delivering measurable financial return.
We don’t add another point solution.We replace fragmentation with a unified model.
Onsera is a closed-loop system that turns cardiometabolic spend from a liability into a managed outcome.
Built for speed, access, and measurable outcomes—our guarantees ensure your population gets the care they need, when they need it, with results you can track.
We don’t ask you to wait for results. We show you what’s possible before you even start.
Onsera exists to close the gap between what healthcare promises—and what it actually delivers.
For your people, that means better health, energy, and quality of life. For your business, it means measurable cost reduction and long-term sustainability.
Onsera goes straight to the manufacturers, so the fund gets the best market price on the medications driving its biggest spend. The result is a GLP-1 line item that behaves like a managed program.
Eligibility follows your plan design and applies to participants and dependents meeting clinical criteria: BMI ≥ 30, BMI ≥ 27 with comorbidity, or early cardiometabolic risk.
Better adherence. Lower cost. Measurable outcomes.
